Product Details
Place of Origin: China
Document: Product Brochure PDF
Payment & Shipping Terms
Minimum Order Quantity: 10Grams
Price: USD
Packaging Details: 1kg/Foil Bag
Delivery Time: 3-7days after received payment
Payment Terms: T/T, Western Union,PayPal
Supply Ability: 5000KG Per Year
Product Name: |
Boldenone Acetate |
Cas: |
846-46-0 |
Appearance: |
White Powder |
Purity: |
99% |
Usage: |
Muscle Building |
Product Name: |
Boldenone Acetate |
Cas: |
846-46-0 |
Appearance: |
White Powder |
Purity: |
99% |
Usage: |
Muscle Building |
Pure API Raw Powder Boldenone Acetate CAS 846-46-0 For Muscle Building
Description:
Boldenone acetate possesses an acetate ester of fast action which generates a quick substance release into the bloodstream, unlike cypionate and undecylenate which takes 2 days.
Effect :
1. improve physique and performance
2. use for bodybuilding
3. It remains marketed for veterinary use in Australia and the United States
Adverse effects & side effect:
Known possible side effects of AAS include:
1. Dermatological/integumental: oily skin, acne vulgaris, acne conglobata, seborrhea, stretch marks (due to rapid muscle enlargement), hypertrichosis (excessive body hair growth), androgenic alopecia (pattern hair loss; scalp baldness), fluid retention/edema.
2. Child-specific: premature epiphyseal closure and associated short stature, precocious puberty in boys, delayed puberty and contrasexual precocity in girls.
3. Psychiatric/neurological: mood swings, irritability, aggression, violent behavior, impulsivity/recklessness, hypomania/mania, euphoria, depression, anxiety, dysphoria, suicidality, delusions, psychosis, withdrawal, dependence, neurotoxicity, cognitive impairment.
4. Musculoskeletal: muscle hypertrophy, muscle strains, tendon ruptures, rhabdomyolysis.
5. Cardiovascular: dyslipidemia (e.g., increased LDL levels, decreased HDL levels, reduced apo-A1 levels), atherosclerosis, hypertension, left ventricular hypertrophy, cardiomyopathy, myocardial hypertrophy, polycythemia/erythrocytosis, arrhythmias, thrombosis (e.g., embolism, stroke), myocardial infarction, sudden death.
6. Hepatic: elevated liver function tests (AST, ALT, bilirubin, LDH, ALP), hepatotoxicity, jaundice, hepatic steatosis, hepatocellular adenoma, hepatocellular carcinoma, cholestasis, peliosis hepatis; all mostly or exclusively with 17α-alkylated AAS.
7. Renal: renal hypertrophy, nephropathy, acute renal failure (secondary to rhabdomyolysis), focal segmental glomerulosclerosis, renal cell carcinoma.
8. Others: glucose intolerance, insulin resistance, immune dysfunction.
FAQ:
